Physician profile
Justin E Trivax
NPI 1174566095
$119,346.12
in general payments reported to CMS, 2019-2025
52 companies · $1,702 in 2025
The $1,702 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $14K · 2021: $20K · 2022: $19K · 2023: $13K · 2024: $11K · 2025: $1,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $5,934 · Consulting Fee: $31.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,397.00 |
| Food and Beverage | $5,933.64 |
| Consulting Fee | $31.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $94,986.53 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $9,627.00 | 2019-2025 | |
| Medtronic, INC. | $2,709.76 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Boston Scientific Corporation | $2,408.15 | 2019-2025 | Avvigo Guidance System, Cds - Mct/Cem Monitoring, Synergy |
| Medtronic Vascular, INC. | $1,506.11 | 2019-2020 | |
| Amgen INC. | $1,163.79 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $772.70 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $588.63 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $509.63 | 2019-2025 | Wainua, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $420.63 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $419.80 | 2020-2025 | Onpattro, Amvuttra |
| Pfizer INC. | $410.63 | 2019-2024 | |
| Lilly USA, LLC | $379.02 | 2023-2025 | Mounjaro, Zepbound |
| Esperion Therapeutics, INC. | $375.66 | 2020-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.69 | 2019-2025 | Jardiance |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $212.12 | 2023-2024 | Symphony Catheter, Prodigy Catheter |
| Amarin Pharma, INC. | $211.04 | 2019-2021 | |
| Novo Nordisk INC | $198.30 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $162.07 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Amplatzer Amulet |
| Penumbra, INC. | $150.35 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $148.50 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $135.46 | 2020-2023 | Kengreal |
| Actelion Pharmaceuticals US, INC. | $132.43 | 2019-2025 | Opsumit, Uptravi |
| Kowa Pharmaceuticals America, INC. | $125.70 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $119.21 | 2019-2022 | |
| Kiniksa Pharmaceuticals, LTD. | $105.76 | 2022-2023 | Arcalyst |
| Edwards Lifesciences Corporation | $88.64 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kiniksa Pharmaceuticals International, Plc | $87.31 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $86.40 | 2020-2022 | |
| Scpharmaceuticals INC. | $75.29 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $53.65 | 2019-2023 | |
| Tactile Systems Technology INC | $53.53 | 2021-2022 | |
| Heartflow, INC. | $52.13 | 2019-2023 | Ffrct |
| Lundbeck LLC | $50.55 | 2019-2020 | |
| Abiomed | $49.15 | 2023-2025 | Impella |
| Baxter Healthcare | $46.80 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| United Therapeutics Corporation | $46.23 | 2023-2024 | Tyvaso |
| Daiichi Sankyo INC. | $43.09 | 2023 | Injectafer |
| Vital Connect, INC | $38.11 | 2024 | Vitalpatch Rtm |
| Recor Medical INC | $37.32 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Cardiovascular Systems INC. | $32.38 | 2021-2023 | Diamondback Peripheral |
| Medicomp INC | $32.10 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $29.73 | 2025 | Assure Wcd |
| Astellas Pharma US INC | $23.38 | 2019 | |
| Teleflex LLC | $19.64 | 2023 | Guideliner |
| Angiodynamics, INC. | $19.02 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.47 | 2020 | |
| Vivaquant INC, Dba Rhythm Express | $16.00 | 2025 | Rhythm Express |
| Irhythm Technologies, INC. | $15.79 | 2019 | |
| Bridgebio Pharma, INC. | $15.08 | 2025 | Attruby |
| Philips North America LLC | $13.91 | 2019 | |
| Ge Healthcare | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Trivax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.